Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma
Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Michiel van den Brand(Radboud University Nijmegen), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Annemiek B. van Spriel(Radboud University Nijmegen), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Youli Zu(Methodist Hospital), Frederick Hagemeister(The University of Texas MD Anderson Cancer Center), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Charlotte M. de Winde(University College London), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Yong Li(Baylor College of Medicine), Michael Wang(St. Joseph Health System), Jing Wang(The University of Texas MD Anderson Cancer Center), William W.L. Choi(Chinese University of Hong Kong), John C. Byrd(The Ohio State University), Kausar J. Jabbar(Beaumont Health), L. Jeffrey Medeiros(Delaware Division of Libraries), Ling Li(First Affiliated Hospital of Zhengzhou University), Jane N. Winter(Northwestern University)
Cited by 109
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k